Furthermore the number of deaths in the allcause mortality eicacy analysis was 4 22 percent in the patisiran arm and 10 56 percent in the placebo arm determined in accordance with the predefined statistical analysis plan which excluded death due to COVID19 and treated cardiac transplant as a death event consistent with other studies in the field